|1||NCT00225303||Completed||TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use||
||116||All||18 Years and older (Adult, Senior)||NCT00225303||CR006730||March 2005||June 2006||September 23, 2005||May 19, 2011|
|2||NCT01543035||Completed||Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs||
||Other / Industry||
||34||All||18 Years to 70 Years (Adult, Senior)||NCT01543035||ETRALL DR3215||ETRALL||December 2011||July 2013||August 2013||March 2, 2012||December 12, 2013||
† Study has passed its completion date and status has not been verified in more than two years.